The Department of Pharmaceuticals (DoP) has revised the guidelines of the production linked incentive (PLI) schemes for promotion of bulk drugs and medical devices, revising the provisions related to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback